soul trial oral semaglutide cardiovascular outcomes trial SOUL: Bests Usual Care in High-Risk Type 2 Diabetes semaglutide cardiovascular trial SOUL: Oral

Zepbound 10 mg and 12 mg were out of stock in 4 of the last 8 weeks

Not just the drug itself but the delivery systems

It belongs to a class of medications called GLP-1 receptor agonists, which work by stimulating insulin release in response to meals, reducing glucagon secretion, and slowing gastric emptying all of which help control blood sugar levels in adults with type 2 diabetes

Implementing preventive strategies such as a balanced diet, lifestyle modifications, and seeking medical interventions can help mitigate hair loss concerns associated with GLP-1 use

Studies including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have demonstrated reduced cardiovascular events in patients with type 2 diabetes